1. Home
  2. WPRT vs ATNM Comparison

WPRT vs ATNM Comparison

Compare WPRT & ATNM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Westport Fuel Systems Inc

WPRT

Westport Fuel Systems Inc

HOLD

Current Price

$2.09

Market Cap

39.3M

Sector

Industrials

ML Signal

HOLD

Logo Actinium Pharmaceuticals Inc. (Delaware)

ATNM

Actinium Pharmaceuticals Inc. (Delaware)

HOLD

Current Price

$0.93

Market Cap

31.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WPRT
ATNM
Founded
1995
2000
Country
Canada
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
39.3M
31.7M
IPO Year
2006
2013

Fundamental Metrics

Financial Performance
Metric
WPRT
ATNM
Price
$2.09
$0.93
Analyst Decision
Buy
Strong Buy
Analyst Count
2
2
Target Price
$4.38
$4.50
AVG Volume (30 Days)
841.5K
120.9K
Earning Date
04-23-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
14.17
EPS
N/A
N/A
Revenue
N/A
$90,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$28.74
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
11.11
52 Week Low
$1.54
$0.94
52 Week High
$4.14
$1.89

Technical Indicators

Market Signals
Indicator
WPRT
ATNM
Relative Strength Index (RSI) 49.67 38.79
Support Level $1.75 N/A
Resistance Level $2.15 $1.27
Average True Range (ATR) 0.21 0.05
MACD -0.02 0.00
Stochastic Oscillator 40.74 15.38

Price Performance

Historical Comparison
WPRT
ATNM

About WPRT Westport Fuel Systems Inc

Westport Fuel Systems Inc is an organization engaged in the engineering, manufacturing, and supply of alternative fuel systems and components for transportation applications. It has three reportable segments: High-Pressure Controls, Heavy-Duty OEM, and Cespira. It derives maximum revenue from Heavy-Duty OEM segment. Heavy-Duty OEM segment's products include HPDI related fuel system solutions and components. Geographically, the company operates in Europe, America and Asia, of which it generates maximum revenue from Europe. It also develops and supplies advanced LPG, CNG, LNG and H2 systems and components for OEM (original equipment manufacturer) D-OEM (delayed oem) and After Market (retrofit market) world-wide.

About ATNM Actinium Pharmaceuticals Inc. (Delaware)

Actinium Pharmaceuticals Inc is a biopharmaceutical company engaged in the development of targeted radiotherapies using its Antibody Radiation Conjugates (ARCs) platform, which combines monoclonal antibodies with radioisotopes to selectively target and destroy cancer cells. The company's product candidates include Iomab-B, an iodine-131 based radiotherapy for conditioning prior to hematopoietic stem cell transplantation, and Actimab-A, an actinium-225 based radiotherapy in clinical development for acute myeloid leukemia. The company is also advancing additional programs, including Iomab-ACT for cell and gene therapy conditioning and other preclinical candidates targeting solid tumors.

Share on Social Networks: